Market Cap (In AUD)
42.99 Million
Revenue (In AUD)
-
Net Income (In AUD)
-14 Million
Avg. Volume
23.29 Thousand
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.185-0.56
- PE
- -
- EPS
- -
- Beta Value
- -0.044
- ISIN
- AU0000182412
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Mr. Mathew Regan
- Employee Count
- -
- Website
- https://www.artrya.com
- Ipo Date
- 2021-11-25
- Details
- Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. The company was incorporated in 2018 and is based in West Perth, Australia.
More Stocks
-
NER
-
SPNS
-
BIOCQBiocept, Inc.
BIOCQ
-
ASND
-
AGRUFAF Gruppen ASA
AGRUF
-
6H90Healwell AI Inc
6H90
-
002181
-
HTCMF